Mayne Pharma Group Limited (MAYNF) Shareholder/Analyst Call Transcript

Core Points - Mayne Pharma's 2025 Annual General Meeting (AGM) is being held in Melbourne, Australia, following an extension granted by the Australian Securities and Investment Commission due to a scheme of arrangement with Cosette Pharmaceuticals that did not complete as expected [1] - The AGM is conducted in a hybrid format, allowing shareholders to participate either in person or via a live webcast [2] - Voting for all resolutions is open during the AGM, and shareholders can change their votes until the voting is officially closed [3]